Juturna Bio, an EPFL spin-off based at the Campus Biotech, is developing epigenetic therapies to restore the function of ageing brain cells, with Alzheimer's as the first target. A CHF 50,000 FIF grant funds a translational proof of concept.
- Announced on
- Round
- Grant
- Amount
- CHF 50,000
- Location
- Geneva
- Sector
- Biotech & life sciences
Investors
- FIF Genève lead
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic